Pharmaceuticals: Major
US companies operating in the same pharmaceuticals: major industry
The table below has US companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Eli Lilly and Company, or spot the most traded options, such as Processa Pharmaceuticals, Inc.. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 754.11 B USD | 795.70 USD | −1.47% | 1.55 M | 0.52 | 65.92 | 12.07 USD | +80.78% | 0.69% | Health technology | Buy |
 JNJJohnson & Johnson | 369.13 B USD | 153.42 USD | −1.16% | 1.9 M | 0.29 | 17.05 | 9.00 USD | +29.58% | 3.23% | Health technology | Buy |
 NVONovo Nordisk A/SDR | 341.84 B USD | 74.53 USD | −3.23% | 4.85 M | 0.54 | 22.11 | 3.37 USD | +16.43% | 1.53% | Health technology | Buy |
 ABBVAbbVie Inc. | 330.11 B USD | 186.89 USD | −2.08% | 1.8 M | 0.40 | 79.69 | 2.35 USD | −30.17% | 3.34% | Health technology | Buy |
 AZNAstraZeneca PLCDR | 227.69 B USD | 71.79 USD | −2.40% | 2.1 M | 0.61 | 28.84 | 2.49 USD | +22.68% | 2.07% | Health technology | Strong buy |
 NVSNovartis AGDR | 224.87 B USD | 117.22 USD | −0.74% | 732.19 K | 0.66 | 18.35 | 6.39 USD | −13.30% | 2.78% | Health technology | Neutral |
 MRKMerck & Company, Inc. | 198.74 B USD | 79.15 USD | −2.24% | 5.21 M | 0.38 | 11.52 | 6.87 USD | +664.64% | 3.90% | Health technology | Buy |
 PFEPfizer, Inc. | 137.39 B USD | 24.17 USD | −0.96% | 17.34 M | 0.47 | 17.51 | 1.38 USD | — | 6.97% | Health technology | Buy |
 SNYSanofiDR | 121.09 B USD | 48.57 USD | −1.70% | 977.83 K | 0.51 | 20.29 | 2.39 USD | +3.07% | 3.24% | Health technology | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 114.57 B USD | 446.15 USD | −1.06% | 530.58 K | 0.47 | — | −3.92 USD | −125.45% | 0.00% | Health technology | Buy |
 BMYBristol-Myers Squibb Company | 96.9 B USD | 47.62 USD | −2.15% | 4.68 M | 0.42 | 17.88 | 2.66 USD | — | 5.01% | Health technology | Neutral |
 GSKGSK plcDR | 81.67 B USD | 40.09 USD | −0.99% | 2.07 M | 0.46 | 20.81 | 1.93 USD | −29.97% | 3.89% | Health technology | Neutral |
 ZTSZoetis Inc. | 72.59 B USD | 163.04 USD | −0.82% | 972.8 K | 0.36 | 29.28 | 5.57 USD | +7.34% | 1.13% | Health technology | Strong buy |
 REGNRegeneron Pharmaceuticals, Inc. | 55.89 B USD | 517.63 USD | −0.97% | 369.4 K | 0.25 | 13.18 | 39.29 USD | +16.05% | 0.34% | Health technology | Buy |
 HLNHaleon plcDR | 47.72 B USD | 10.56 USD | −1.54% | 8.03 M | 0.55 | 26.28 | 0.40 USD | +42.97% | 1.65% | Health technology | Buy |
 TAKTakeda Pharmaceutical Company LimitedDR | 47.47 B USD | 14.94 USD | −0.90% | 1.01 M | 0.53 | 68.73 | 0.22 USD | −32.20% | 3.89% | Health technology | Buy |
 ALNYAlnylam Pharmaceuticals, Inc. | 40.08 B USD | 307.42 USD | −0.44% | 270.17 K | 0.40 | — | −2.09 USD | +21.99% | 0.00% | Health technology | Buy |
 RGCRegencell Bioscience Holdings Limited | 36.11 B USD | 73.02 USD | +21.70% | 2.36 M | 1.58 | — | — | — | 0.00% | Health technology | — |
 ONCBeOne Medicines Ltd.DR | 33.27 B USD | 253.61 USD | −4.09% | 204.67 K | 0.55 | — | −3.71 USD | +50.93% | 0.00% | Health technology | Strong buy |
 RPRXRoyalty Pharma plc | 19.49 B USD | 34.66 USD | −1.25% | 1.03 M | 0.23 | 14.13 | 2.45 USD | +37.66% | 2.45% | Health technology | Buy |
 INSMInsmed Incorporated | 19.16 B USD | 100.88 USD | −0.70% | 1.11 M | 0.20 | — | −5.95 USD | −13.60% | 0.00% | Health technology | Strong buy |
 BIIBBiogen Inc. | 18.85 B USD | 128.62 USD | −1.85% | 377.63 K | 0.30 | 12.70 | 10.13 USD | +26.48% | 0.00% | Health technology | Buy |
 GMABGenmab A/SDR | 14.01 B USD | 22.18 USD | −3.00% | 564.56 K | 0.51 | 12.58 | 1.76 USD | +46.17% | 0.00% | Health technology | Buy |
 INCYIncyte Corporation | 13.52 B USD | 69.83 USD | −1.94% | 655.78 K | 0.28 | 216.07 | 0.32 USD | −90.19% | 0.00% | Health technology | Buy |
 RDYDr. Reddy's Laboratories LtdDR | 13.06 B USD | 15.29 USD | −2.77% | 762.55 K | 0.38 | 19.08 | 0.80 USD | −0.76% | 0.51% | Health technology | Neutral |
 UTHRUnited Therapeutics Corporation | 12.94 B USD | 286.91 USD | −0.57% | 207.12 K | 0.23 | 11.45 | 25.06 USD | +18.48% | 0.00% | Health technology | Buy |
 EXELExelixis, Inc. | 11.3 B USD | 41.44 USD | −0.74% | 731.46 K | 0.31 | 18.80 | 2.20 USD | +240.89% | 0.00% | Health technology | Buy |
 ASNDAscendis Pharma A/SDR | 10.73 B USD | 177.76 USD | +0.03% | 158.78 K | 0.37 | — | −6.29 USD | +34.71% | 0.00% | Health technology | Strong buy |
 VTRSViatris Inc. | 10.35 B USD | 8.82 USD | −1.95% | 2.9 M | 0.21 | — | −3.18 USD | −6,283.33% | 5.34% | Health technology | Neutral |
 VRNAVerona Pharma plcDR | 7.89 B USD | 92.17 USD | −0.57% | 321.86 K | 0.23 | — | −2.04 USD | −157.53% | 0.00% | Health technology | Strong buy |
 CORTCorcept Therapeutics Incorporated | 7.62 B USD | 71.87 USD | +1.37% | 327.71 K | 0.27 | 62.38 | 1.15 USD | +8.56% | 0.00% | Health technology | Strong buy |
 GRFSGrifols, S.A.DR | 7.51 B USD | 8.99 USD | −1.05% | 232.09 K | 0.33 | 29.24 | 0.31 USD | +1.92% | 0.00% | Health technology | Neutral |
 ROIVRoivant Sciences Ltd. | 7.47 B USD | 11.00 USD | −0.77% | 1.89 M | 0.36 | — | −0.25 USD | −104.91% | 0.00% | Health technology | Strong buy |
 RGENRepligen Corporation | 6.98 B USD | 124.16 USD | −1.53% | 226.34 K | 0.34 | — | −0.41 USD | −200.76% | 0.00% | Health technology | Buy |
 LEGNLegend Biotech CorporationDR | 6.6 B USD | 34.60 USD | −3.46% | 873.84 K | 0.33 | — | −1.19 USD | +54.33% | 0.00% | Health technology | Strong buy |
 JAZZJazz Pharmaceuticals plc | 6.54 B USD | 108.13 USD | −1.38% | 197.06 K | 0.30 | 14.58 | 7.42 USD | +61.30% | 0.00% | Health technology | Strong buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 6.18 B USD | 278.54 USD | −2.29% | 76.29 K | 0.25 | — | −18.04 USD | +21.83% | 0.00% | Health technology | Strong buy |
 IONSIonis Pharmaceuticals, Inc. | 5.68 B USD | 35.70 USD | +1.31% | 667.02 K | 0.45 | — | −2.98 USD | −11.81% | 0.00% | Health technology | Buy |
 TGTXTG Therapeutics, Inc. | 5.57 B USD | 35.11 USD | −1.46% | 754.79 K | 0.41 | 143.89 | 0.24 USD | +10.66% | 0.00% | Health technology | Strong buy |
 ALKSAlkermes plc | 4.92 B USD | 29.87 USD | +1.52% | 1.08 M | 0.79 | 14.22 | 2.10 USD | −17.17% | 0.00% | Health technology | Buy |
 AKROAkero Therapeutics, Inc. | 4.4 B USD | 55.16 USD | −1.06% | 313.14 K | 0.19 | — | −3.75 USD | −17.04% | 0.00% | Health technology | Strong buy |
 PBHPrestige Consumer Healthcare Inc. | 4.13 B USD | 83.53 USD | −0.14% | 104.48 K | 0.41 | 19.49 | 4.29 USD | +2.73% | 0.00% | Health technology | Buy |
 PTCTPTC Therapeutics, Inc. | 4.07 B USD | 51.31 USD | −1.08% | 326.36 K | 0.35 | 7.88 | 6.51 USD | — | 0.00% | Health technology | Buy |
 CYTKCytokinetics, Incorporated | 3.91 B USD | 32.73 USD | −3.11% | 380.54 K | 0.28 | — | −5.31 USD | +1.75% | 0.00% | Health technology | Strong buy |
 SLNOSoleno Therapeutics, Inc. | 3.88 B USD | 76.91 USD | −1.59% | 328.91 K | 0.50 | — | −4.62 USD | −72.19% | 0.00% | Health technology | Strong buy |
 ACADACADIA Pharmaceuticals Inc. | 3.77 B USD | 22.51 USD | +1.67% | 907.56 K | 0.62 | 16.39 | 1.37 USD | — | 0.00% | Health technology | Buy |
 PRGOPerrigo Company plc | 3.64 B USD | 26.45 USD | −0.90% | 219.15 K | 0.19 | — | −1.27 USD | −4,006.15% | 4.24% | Health technology | Buy |
 RAREUltragenyx Pharmaceutical Inc. | 3.46 B USD | 36.55 USD | −1.51% | 233.96 K | 0.20 | — | −5.88 USD | +26.72% | 0.00% | Health technology | Strong buy |
 VKTXViking Therapeutics, Inc. | 2.95 B USD | 26.26 USD | −2.61% | 946.44 K | 0.28 | — | −1.15 USD | −23.84% | 0.00% | Health technology | Strong buy |
 HCMHUTCHMED (China) LimitedDR | 2.93 B USD | 15.79 USD | −5.96% | 37.22 K | 0.31 | 73.07 | 0.22 USD | −62.40% | 0.00% | Health technology | Strong buy |
 CRNXCrinetics Pharmaceuticals, Inc. | 2.89 B USD | 30.87 USD | −1.06% | 146.5 K | 0.27 | — | −3.82 USD | −1.20% | 0.00% | Health technology | Strong buy |
 CPRXCatalyst Pharmaceuticals, Inc. | 2.85 B USD | 23.37 USD | −1.27% | 474.42 K | 0.34 | 14.91 | 1.57 USD | +191.05% | 0.00% | Health technology | Strong buy |
 AAPGAscentage Pharma Group International - American Depository SharesDR | 2.78 B USD | 31.79 USD | −1.06% | 2.83 K | 0.20 | — | −0.75 USD | +59.15% | 0.00% | Health technology | Strong buy |
 MLTXMoonLake Immunotherapeutics | 2.73 B USD | 42.57 USD | −0.77% | 122.52 K | 0.11 | — | −2.30 USD | −206.92% | 0.00% | Health technology | Strong buy |
 OGNOrganon & Co. | 2.59 B USD | 9.98 USD | −2.06% | 728.54 K | 0.17 | 3.45 | 2.89 USD | −29.15% | 8.44% | Health technology | Neutral |
 MTSRMetsera, Inc. | 2.57 B USD | 24.47 USD | −8.93% | 516.24 K | 0.45 | — | — | — | 0.00% | Health technology | Strong buy |
 AMRXAmneal Pharmaceuticals, Inc. | 2.52 B USD | 8.05 USD | −0.80% | 468.64 K | 0.26 | — | −0.04 USD | +92.15% | 0.00% | Health technology | Strong buy |
 MIRMMirum Pharmaceuticals, Inc. | 2.52 B USD | 50.88 USD | +0.91% | 161.46 K | 0.36 | — | −1.61 USD | +57.12% | 0.00% | Health technology | Strong buy |
 IBRXImmunityBio, Inc. | 2.48 B USD | 2.81 USD | −10.22% | 5.82 M | 0.45 | — | −0.58 USD | +44.53% | 0.00% | Health technology | Strong buy |
 BGMBGM Group Ltd. | 2.43 B USD | 13.20 USD | −6.38% | 66.56 K | 0.58 | — | −0.20 USD | +81.70% | 0.00% | Health technology | — |
 XENEXenon Pharmaceuticals Inc. | 2.42 B USD | 31.60 USD | −1.33% | 133.52 K | 0.18 | — | −3.22 USD | −18.58% | 0.00% | Health technology | Strong buy |
 APLSApellis Pharmaceuticals, Inc. | 2.26 B USD | 17.97 USD | −1.80% | 343.16 K | 0.19 | — | −1.79 USD | +48.16% | 0.00% | Health technology | Buy |
 LGNDLigand Pharmaceuticals Incorporated | 2.17 B USD | 112.57 USD | −2.12% | 50.52 K | 0.44 | — | −7.12 USD | −233.81% | 0.00% | Health technology | Strong buy |
 SRPTSarepta Therapeutics, Inc. | 2.16 B USD | 22.00 USD | +5.06% | 8.94 M | 1.20 | — | −2.58 USD | −3,975.64% | 0.00% | Health technology | Buy |
 NAMSNewAmsterdam Pharma Company N.V. | 2.13 B USD | 18.98 USD | −3.92% | 224 K | 0.19 | — | −1.88 USD | −1,314.68% | 0.00% | Health technology | Strong buy |
 VCELVericel Corporation | 2.1 B USD | 41.67 USD | +0.19% | 139.84 K | 0.38 | 1,054.94 | 0.04 USD | — | 0.00% | Health technology | Strong buy |
 KNSAKiniksa Pharmaceuticals, Ltd. | 2.03 B USD | 27.80 USD | −2.15% | 203.59 K | 0.23 | — | −0.24 USD | −324.19% | 0.00% | Health technology | Strong buy |
 AGIOAgios Pharmaceuticals, Inc. | 2.02 B USD | 34.82 USD | −2.62% | 147.92 K | 0.28 | 3.08 | 11.29 USD | — | 0.00% | Health technology | Buy |
 BLTEBelite Bio, IncDR | 1.95 B USD | 59.39 USD | −1.00% | 13.5 K | 0.42 | — | −1.36 USD | −15.56% | 0.00% | Health technology | Strong buy |
 IDYAIDEAYA Biosciences, Inc. | 1.92 B USD | 21.93 USD | −2.05% | 228.27 K | 0.22 | — | −3.59 USD | −79.25% | 0.00% | Health technology | Strong buy |
 HRMYHarmony Biosciences Holdings, Inc. | 1.89 B USD | 32.85 USD | −0.14% | 214.06 K | 0.34 | 12.53 | 2.62 USD | +13.25% | 0.00% | Health technology | Strong buy |
 SUPNSupernus Pharmaceuticals, Inc. | 1.82 B USD | 32.57 USD | +0.31% | 360.25 K | 0.60 | 29.49 | 1.10 USD | — | 0.00% | Health technology | Buy |
 FOLDAmicus Therapeutics, Inc. | 1.8 B USD | 5.86 USD | −3.14% | 2.23 M | 0.48 | — | −0.09 USD | +80.86% | 0.00% | Health technology | Strong buy |
 INDVIndivior PLC | 1.72 B USD | 13.82 USD | −2.54% | 471.17 K | 0.37 | — | −0.23 USD | −1,980.17% | 0.00% | Health technology | Strong buy |
 TARSTarsus Pharmaceuticals, Inc. | 1.71 B USD | 40.71 USD | −1.40% | 140.3 K | 0.25 | — | −2.73 USD | +42.86% | 0.00% | Health technology | Strong buy |
 CNTACentessa Pharmaceuticals plcDR | 1.68 B USD | 12.63 USD | +0.20% | 618.48 K | 0.47 | — | −1.80 USD | −26.97% | 0.00% | Health technology | Strong buy |
 ARQTArcutis Biotherapeutics, Inc. | 1.57 B USD | 13.13 USD | −2.01% | 474.4 K | 0.25 | — | −1.04 USD | +64.22% | 0.00% | Health technology | Strong buy |
 BHVNBiohaven Ltd. | 1.5 B USD | 14.66 USD | −3.43% | 554.9 K | 0.31 | — | −9.37 USD | −37.00% | 0.00% | Health technology | Strong buy |
 SPRYARS Pharmaceuticals, Inc. | 1.48 B USD | 15.04 USD | −0.79% | 256.32 K | 0.26 | — | −0.16 USD | +68.69% | 0.00% | Health technology | Strong buy |
 EVOEvotec SEDR | 1.46 B USD | 4.08 USD | −1.33% | 247.5 K | 2.24 | — | −0.63 USD | −125.61% | 0.00% | Health technology | Buy |
 ETNB89bio, Inc. | 1.44 B USD | 9.84 USD | −2.09% | 791.83 K | 0.32 | — | −3.38 USD | −68.13% | 0.00% | Health technology | Strong buy |
 OCULOcular Therapeutix, Inc. | 1.35 B USD | 8.49 USD | −2.97% | 616.91 K | 0.19 | — | −1.15 USD | +15.26% | 0.00% | Health technology | Strong buy |
 INVAInnoviva, Inc. | 1.34 B USD | 21.35 USD | −2.06% | 550.98 K | 0.47 | — | −1.00 USD | −144.70% | 0.00% | Health technology | Strong buy |
 TVTXTravere Therapeutics, Inc. | 1.27 B USD | 14.30 USD | −2.59% | 304.17 K | 0.19 | — | −2.80 USD | +44.52% | 0.00% | Health technology | Strong buy |
 AMPHAmphastar Pharmaceuticals, Inc. | 1.22 B USD | 25.80 USD | −0.69% | 98.94 K | 0.21 | 9.36 | 2.76 USD | −5.04% | 0.00% | Health technology | Buy |
 VRDNViridian Therapeutics, Inc. | 1.2 B USD | 14.76 USD | −7.43% | 266.74 K | 0.37 | — | −4.05 USD | +10.13% | 0.00% | Health technology | Strong buy |
 LQDALiquidia Corporation | 1.16 B USD | 13.62 USD | −3.34% | 1.09 M | 0.32 | — | −1.56 USD | +0.26% | 0.00% | Health technology | Strong buy |
 PCRXPacira BioSciences, Inc. | 1.15 B USD | 24.76 USD | +1.73% | 122.58 K | 0.20 | — | −2.29 USD | −264.46% | 0.00% | Health technology | Buy |
 HROWHarrow, Inc. | 1.14 B USD | 31.19 USD | −1.11% | 115.02 K | 0.27 | — | −0.61 USD | +33.18% | 0.00% | Health technology | Strong buy |
 MNKDMannKind Corporation | 1.14 B USD | 3.76 USD | −1.44% | 945.66 K | 0.36 | 37.66 | 0.10 USD | +322.46% | 0.00% | Health technology | Strong buy |
 RAPTRAPT Therapeutics, Inc. | 1.09 B USD | 8.05 USD | −2.30% | 66.82 K | 1.00 | — | −19.25 USD | +21.69% | 0.00% | Health technology | Buy |
 OCSOculis Holding AG | 1.05 B USD | 19.30 USD | +0.31% | 4.93 K | 0.13 | — | −2.65 USD | −43.02% | 0.00% | Health technology | Strong buy |
 PAHCPhibro Animal Health Corporation | 997.13 M USD | 24.60 USD | −0.45% | 119.12 K | 0.62 | 31.48 | 0.78 USD | +140.54% | 1.94% | Health technology | Neutral |
 COLLCollegium Pharmaceutical, Inc. | 961.69 M USD | 29.92 USD | +0.71% | 123.98 K | 0.46 | 24.66 | 1.21 USD | −49.45% | 0.00% | Health technology | Strong buy |
 AVDLAvadel Pharmaceuticals plc | 922.89 M USD | 9.54 USD | +0.42% | 581.22 K | 0.40 | — | −0.27 USD | +85.10% | 0.00% | Health technology | Strong buy |
 AKBAAkebia Therapeutics, Inc. | 916.6 M USD | 3.49 USD | −2.51% | 2.25 M | 0.31 | — | −0.22 USD | +2.76% | 0.00% | Health technology | Strong buy |
 PHVSPharvaris N.V. | 908.67 M USD | 16.68 USD | −1.68% | 2.2 K | 0.04 | — | −3.02 USD | −18.08% | 0.00% | Health technology | Strong buy |
 NRIXNurix Therapeutics, Inc. | 879.76 M USD | 11.54 USD | −3.11% | 147.79 K | 0.18 | — | −2.81 USD | −5.92% | 0.00% | Health technology | Strong buy |
 PRAXPraxis Precision Medicines, Inc. | 878.31 M USD | 43.12 USD | −1.57% | 35.73 K | 0.11 | — | −10.71 USD | +32.69% | 0.00% | Health technology | Strong buy |
 ZYMEZymeworks Inc. | 859.2 M USD | 12.23 USD | −3.32% | 55.73 K | 0.13 | — | −1.50 USD | +15.96% | 0.00% | Health technology | Buy |